Four risk prediction models have been shown to accurately select the highest risk smokers for lung cancer screening. READ MORE
A recently approved second-line therapy is reasonably effective in the treatment of advanced non-small cell lung cancer, according to a recent real-world study.
A new signature detection platform uses tumor-educated platelet RNA profiles to detect non-small-cell lung cancer.
The number of eligibility criteria and screening procedures in lung cancer clinical trials continue to rise.